Group structure
4 companies in 2 countries
United States1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
1–25 of 97
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| 8-SYMPTOM RELIEF0.05 % / w/v + 0.25 % / w/v · Solution | Tetryzoline, Zinc | Canada | Marketed | 2016 |
| ADVANCED RELIEF EYE DROPS0.1 % / w/v + 1 % / w/v + 1 % / w/v + 0.05 % / w/v · Solution | Dextran, Macrogol, Povidone, Tetryzoline | Canada | Marketed | 2010 |
| ALLERGY EYE DROPS0.05 % / w/v + 0.25 % / w/v · Solution | Tetryzoline, Zinc | Canada | Marketed | 2007 |
| ALLERGY RELIEF LIQUID GELS10 mg · Capsule | Cetirizine | Canada | Marketed | 2023 |
| ARGATROBAN FOR INJECTION100 mg / ml · Solution | Argatroban | Canada | Marketed | 2026 |
| ARTIFICIAL TEARS0.2 % / w/v + 0.2 % / w/v · Solution | Glycerine, Hypromellose | Canada | Marketed | 2011 |
| BIMATOPROST RC0.01 % / w/v · Solution | Bimatoprost | Canada | Marketed | 2026 |
| BIVALIRUDIN FOR INJECTION250 mg / vial · Powder For Solution | Bivalirudin | Canada | Marketed | 2023 |
| BORTEZOMIB FOR INJECTION3.5 mg / vial · Powder For Solution | Bortezomib | Canada | Marketed | 2023 |
| Breyanzi4.6ml/vial · Injection | Lisocabtagene maraleucel | United States | Marketed | 2021 |
| CALCIUM CHLORIDE INJECTION USP100 mg / ml · Solution | Calcium chloride | Canada | Marketed | 1990 |
| CARBETOCIN INJECTION100 mcg / ml · Solution | Carbetocin | Canada | Marketed | 2020 |
| CARBOPROST TROMETHAMINE INJECTION USP250 mcg / ml · Solution | Carboprost | Canada | Marketed | 2024 |
| CASPOFUNGIN FOR INJECTION70 mg / vial · Powder For Solution | Caspofungin | Canada | Marketed | 2017 |
| CASPOFUNGIN FOR INJECTION50 mg / vial · Powder For Solution | Caspofungin | Canada | Marketed | 2017 |
| CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE2 mg / ml · Solution | Cisatracurium | Canada | Marketed | 2014 |
| CISATRACURIUM SINGLE DOSE2 mg / ml · Solution | Cisatracurium | Canada | Not marketed | 2014 |
| COUGH & COLD RELIEF500 mg / sachet + 20 mg / sachet + 10 mg / sachet · Powder For Solution | Paracetamol, Dextromethorphan, Phenylephrine | Canada | Marketed | 2020 |
| DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP100 mcg / ml · Solution | Dexmedetomidine | Canada | Marketed | 2019 |
| DEXMEDETOMIDINE HYDROCHLORIDE INJECTION400 mcg / 100 ml · Solution | Dexmedetomidine | Canada | Marketed | 2020 |
| DEXMEDETOMIDINE HYDROCHLORIDE INJECTION200 mcg / 50 ml · Solution | Dexmedetomidine | Canada | Marketed | 2020 |
| DEXRAZOXANE FOR INJECTION250 mg / vial · Powder For Solution | Dexrazoxane | Canada | Marketed | 2025 |
| DIARRHEA RELIEF FAST DISSOLVE2 mg · Tablet (Orally-Disintegrating) | Loperamide | Canada | Marketed | 2022 |
| DIARRHEA RELIEF LIQUID CAPSULES2 mg · Capsule | Loperamide | Canada | Authorised | |
| DRY EYE TEARS0.2 % / w/v + 0.2 % / w/v · Solution | Glycerine, Hypromellose | Canada | Marketed | 2014 |